PHS
AXNX

PFM Health Sciences’s Axonics, Inc. Common Stock AXNX Stock Holding History

PFM Health Sciences’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-550,026
Closed -$15.2M – 82
2019
Q4 		$15.2M Buy
550,026
+298,565
+119% +$7.13M 0.73% 40
2019
Q3 		$6.77M Buy
251,461
+145,133
+136% +$5.06M 0.2% 61
2019
Q2 		$4.36M Buy
+106,328
New +$2.99M 0.08% 78

Other funds holding AXNX

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

PFM Health Sciences's AXNX Position: Q1 2020 in Review

PFM Health Sciences sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2020, closing a stake of 550,026 shares — an estimated $15.2M sold.

PFM Health Sciences first reported a position in AXNX in Q2 2019 and held it in 3 quarters. The position peaked at $15.2M in Q4 2019. 115 funds tracked by Wall St. Rank hold AXNX as of Q1 2020.

  • PFM Health Sciences reported no remaining Axonics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • PFM Health Sciences sold 550,026 Axonics, Inc. Common Stock shares in Q1 2020, an estimated $15.2M.
  • PFM Health Sciences first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • PFM Health Sciences's Axonics, Inc. Common Stock position peaked at $15.2M in Q4 2019.
  • 115 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.